Esperion Therapeutics Inc. Shares Approach 52-Week Low - Market Mover
The shares closed 1.4% above its 52-week low of $4.85, with trading volume lower than its 30 day average
Dec 29, 2021 by Kwhen Finance Editors
Esperion Therapeutics Inc. (ESPR) shares closed today at 1.4% above its 52 week low of $4.85, giving the company a market cap of $143M. The stock is currently down 81.1% year-to-date, down 82.3% over the past 12 months, and down 60.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%.
Trading Activity
- Trading volume this week was 56.0% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc. | -3.0 | -81.1 | -82.3 | ||
| Dow Jones Industrial Average | 0.3 | 20.7 | 22.2 | -0.3 | 23.6 |
| S&P 500 Index | -0.1 | 29.4 | 31.1 | 0.1 | 32.7 |
| Health Care | -0.3 | 23.0 | 24.6 | -0.0 | 27.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -1285.8%
- The company's stock price performance over the past 12 months lags the peer average by -2295.0%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc. | ESPR | 0 | -81.1 | -82.3 | ||
| Peer Avg | N/A | 172.3 | 6.8 | 3.7 | -1.9 | 21.1 |
| Pfizer Inc. | PFE | 17.3 | 67.1 | 65.1 | -4.2 | 82.2 |
| Regeneron Pharmaceuticals, Inc. | REGN | 9.6 | 31.4 | 29.8 | -7.2 | 44.5 |
| Biomarin Pharmaceutical Inc. - Registered Shares | BMRN | 1046.1 | 3.4 | 2.3 | ||
| Ultragenyx Pharmaceutical Inc. | RARE | -15.9 | -40.0 | -51.1 | ||
| Amicus Therapeutics Inc | FOLD | -13.8 | -48.7 | -48.8 | ||
| Lexicon Pharmaceuticals Inc | LXRX | -9.6 | 27.8 | 25.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: